Anti-Crk p38 (phospho Y221) antibody [EPR269Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal Crk p38 phospho Y221 antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
Adapter molecule crk, Proto-oncogene c-Crk, p38, CRK
- WB
Unknown
Western blot - Anti-Crk p38 (phospho Y221) antibody [EPR269Y] (AB76227)
All lanes:
Western blot - Anti-Crk p38 (phospho Y221) antibody [EPR269Y] (ab76227) at 1/2000 dilution
Lane 1:
K562 cell lysate at 10 µg
Lane 2:
K562 cell lysate treated with AP at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 33 kDa
Observed band size: 34 kDa
false
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
World journal of diabetes 16:95092 PubMed40093279
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107884 PubMed37766995
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:3605977 PubMed35096267
2022
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 10:e1004022 PubMed24675776
2014
Applications
WB
Species
Human
International immunopharmacology 17:785-92 PubMed24070708
2013
Applications
Unspecified application
Species
Unspecified reactive species
Molecular & cellular proteomics : MCP 11:355-69 PubMed22499769
2012
Applications
WB
Species
Unspecified reactive species
Molecular cancer therapeutics 9:1419-31 PubMed20423995
2010
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com